We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by Reckitt Benckiser Pty Ltd
I, Leanne McCauley, Director, Advertising Compliance Unit, Regulatory Practice, Education and Compliance Branch and Delegate of the Secretary to the Department of Health, on receipt of an application from Reckitt Benckiser Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representations described in paragraph (a) below for use in advertisements directed to consumers, for the product identified in paragraph (b):
- Please SEEK ADVICE before using this product if you have diabetes as your foot condition may require treatment by a healthcare professional.
- 'Ingrowing Toenail Splinting Kit' (ARTG No. 280215)
Dated this 17th day of November 2016
Leanne McCauley
Delegate of the Secretary to the Department of Health; and
Director
Regulatory Practice, Education and Compliance Branch